LISATA THERAPEUTICS INC

LSTA · NASDAQ

Updated at 2026-10-13 15:18:11

$1.07+1.9%
Today's High
$1.14
Today’s Low
$1.02
LISATA THERAPEUTICS INC (LSTA) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.04
Previous Close
$1.05
Volume
166.66K
Market Cap
$9.46M
P/E Ratio
--
EPS
$-1.14

Previous Day Range

$0.98$1.06

52-Week Range

$0.98$5.07

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
110 ALLEN ROAD, BASKING RIDGE, NJ, UNITED STATES, 07920
Country
US
Listing Date
1995-11-03
Fiscal Year End
December
Shares Outstanding
9.11M
CIK
0000320017

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$100K

2025-09-30

$0

Operating Expenses

2026-06-30

$3.99M

2026-03-31

$4.94M

2025-12-31

$3.17M

2025-09-30

$4.41M

Net Income

2026-06-30

-$2.92M

2026-03-31

-$4.48M

2025-12-31

-$2.95M

2025-09-30

-$4.24M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

-2.95K%

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.54

2026-03-31

$-0.33

2025-12-31

$-0.33

2025-09-30

$-0.49

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$3.98M

2026-03-31

-$4.87M

2025-12-31

-$2.93M

2025-09-30

-$4.2M

Effective Tax Rate

2026-06-30

--

2026-03-31

7.93%

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.